Why is Johnson & Johnson so invested in HIV research and what are you trying to achieve? Jul 20th, 2016 MoJo 567 Views Dr Paul Stoffels, Executive Vice President and Chief Scientific Officer for Johnson & Johnson, answers questions pertinent to the 2016 International AIDS Conference. Business, Lifestyle
